DRTSW

← Markets

DRTSWAlpha Tau Medical Ltd.

Discussion

Nothing said here yet.

to join the conversation.

—

Mon, Aug 10
3:01 PMYahooAlpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Sat, Aug 1
1:16 AMYahooAlpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial
Tue, Jul 21
7:30 AMYahooAlpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success
Wed, Jul 15
7:30 AMYahooAlpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
Sat, Jun 27
2:06 PMYahooAlpha Tau Medical’s (DRTS) First International Brain Cancer Use Tests The Breadth Of Its Alpha DaRT Platform
Tue, Jun 23
7:30 AMYahooAlpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
Thu, Jun 11
7:30 AMYahooAlpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
Wed, Jun 3
7:30 AMYahooAlpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients
Mon, Jun 1
8:00 AMYahooAlpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting
Fri, May 29
8:03 AMmarketbeat.comAlpha Tau Medical Sets Up Catalyst-Rich 2026 as Key Cancer Trial Data Nears
Mon, May 18
3:01 PMYahooAlpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
7:30 AMYahooAlpha Tau to Participate in May Investor Conferences